TY  - GEN
AU  - Ungsedhapand,Chaiwat
AU  - Srasuebkul,Preeyaporn
AU  - Cardiello,Peter
AU  - Ruxrungtham,Kiat
AU  - Ratanasuwan,Winai
AU  - Kroon,Eugene D M B
AU  - Tongtalung,Metta
AU  - Juengprasert,Nittaya
AU  - Ubolyam,Sasiwimol
AU  - Siangphoe,Umaporn
AU  - Emery,Sean
AU  - Lange,Joep M A
AU  - Cooper,David A
AU  - Phanuphak,Praphan
TI  - Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection
SN  - 1525-4135
PY  - 2005///0831
KW  - Adult
KW  - Anti-HIV Agents
KW  - administration & dosage
KW  - Antiretroviral Therapy, Highly Active
KW  - adverse effects
KW  - CD4 Lymphocyte Count
KW  - Didanosine
KW  - Dideoxynucleosides
KW  - Female
KW  - HIV Infections
KW  - drug therapy
KW  - HIV-1
KW  - drug effects
KW  - Humans
KW  - Lamivudine
KW  - Male
KW  - RNA, Viral
KW  - blood
KW  - Retrospective Studies
KW  - Stavudine
KW  - Thailand
KW  - Time Factors
KW  - Zidovudine
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/00126334-200406010-00006
ER  -